Skip to main content

Day: May 12, 2022

GlobalData Plc: Oncology Remains at the Forefront of the Companion Diagnostics Industry

Companion diagnostics (CDx) are developed in parallel to the drug using the drug-diagnostic co-development model LONDON, May 12, 2022 (GLOBE NEWSWIRE) — Oncology remains the largest segment for FDA-defined marketed drugs with CDx. The FDA has cleared or approved more than 40 CDx in the field of oncology. It is expected that oncology will likely remain the therapeutic area at the forefront of CDx in the future. Although precision medicine encompasses many areas, oncology is the area that is expected to exhibit high growth. The Companion Diagnostics Thematic Research Report offered by GlobalData Plc looks at the CDx medical devices market and some of the oncology biomarkers, indications, and diagnostic technologies being utilized. The market for biomarker testing continues to increase due to increases in disease, awareness, improved...

Continue reading

GlobalData Plc: Deposits Remain the Most Popular Investment Avenue in Canada Wealth Management Market

Canada’s affluent segment (covering HNWs and mass affluents) has experienced steady growth in recent years LONDON, May 12, 2022 (GLOBE NEWSWIRE) — In 2019, Canada’s ultra-wealthy population observed an increase in their share of wealth on account of high-performing equity and property markets. Between 2015 and 2019, growth was particularly pronounced in higher wealth bands. However, the pandemic brought the rapid HNW growth to an end. Canadian stock markets were characterized by heightened fluctuations because of falling consumer confidence in the country’s economic performance amid state-induced social distancing restrictions. This resulted in the investor population turning to safe-haven investments to limit their risk exposure. The Canada Wealth Management Market Research Report offered by GlobalData Plc focuses on the HNW segment....

Continue reading

Liquidity Services to Present at the 16th Annual Barrington Research Spring Investment Conference

BETHESDA, Md., May 12, 2022 (GLOBE NEWSWIRE) — Liquidity Services, (Nasdaq:LQDT), a leading global commerce company powering the circular economy, today announced Bill Angrick, Co-Founder, Chairman, and CEO, and Jorge Celaya, Executive Vice President and Chief Financial Officer, will participate in the upcoming Barrington Research Spring Investment Conference on May 19, 2022. The virtual conference will feature meetings with senior management from approximately 40 publicly-traded companies operating in the broadly-defined Business Services, Industrial, Broadcasting, and financial service sectors. Mr. Angrick and Mr. Celaya will conduct individual meetings with investors to discuss how Liquidity Services provides pioneering e-commerce marketplace solutions that continue to power the circular economy and build a better future for...

Continue reading

GlobalData Plc: Augmented Reality Market to Register a Growth Rate of Over 35% by 2030

The global Augmented Reality (AR) market size was worth $7 billion in 2020 LONDON, May 12, 2022 (GLOBE NEWSWIRE) — The AR market is expected to grow at a CAGR of more than 35% during the forecast period. Augmented reality is a technology that allows the user to see the real world overlaid with digital data. AR technology may replace the smartphone as the primary connected device users carry around. Moreover, it will be a critical component of the metaverse – the next mega-theme that Big Tech has in its sights. COVID-19 has also fueled enterprise adoption of AR across sectors such as healthcare, law enforcement, and manufacturing, mainly for remote collaboration. The Augmented Reality Thematic Research Report offered by GlobalData Plc provides an overview of the global augmented reality market and identifies the key trends impacting...

Continue reading

GlobalData Plc: Tech Giants Dominate the Adtech Industry

Advertising technology (adtech) is a blanket term covering all software and services used to deliver and target digital advertisements LONDON, May 12, 2022 (GLOBE NEWSWIRE) — The internet advertising market size was valued at $438 billion in 2021 and will grow at a CAGR of more than 9% during 2021-2030.  The Advertising Tech Thematic Research Report offered by GlobalData Plc provides key trends impacting the growth of the theme over the next 12 to 24 months split into three categories: technology trends, macroeconomic trends, and regulatory trends, and comprehensive industry analysis, including forecasts for the global internet advertising market to 2030. The report gives details of M&A deals driven by the adtech theme, and a timeline highlighting milestones in the development of adtech. It also provides a detailed value chain...

Continue reading

Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress

Accepted abstracts include an oral presentation highlighting quality of life improvements with EMPAVELI® (pegcetacoplan)WALTHAM, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that seven abstracts will be presented at the hybrid European Hematology Association (EHA) Congress to be held June 9-12 in Vienna, Austria. Data to be presented reinforce the robust efficacy and safety profile of EMPAVELI® (pegcetacoplan) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). “Our presence at EHA this year continues to underscore the potential of EMPAVELI to become the new standard of care for all adults living with PNH,” said Federico Grossi, M.D., Ph.D., chief medical officer of Apellis. Oral Presentation:Effect...

Continue reading

Backblaze Launches Channel Partner Program

Combines new Channel Partner team with a package of benefits, rewards, and resources to ease partners’ workload as they engage and grow cloud adoption through the channel SAN MATEO, Calif., May 12, 2022 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading independent storage cloud platform, today announced the launch of its Channel Partner Program. The launch—which follows the recent announcement of a capacity billing model exclusive to the channel, Backblaze B2 Reserve—includes a suite of benefits, rewards, and resources developed to uplevel ease of use and incentives for resellers and distributors who bring B2 Cloud Storage to their customers. “When it comes to helping businesses get the best of what cloud services have to offer, no one does it better than the channel,” Elton Carneiro, Senior Director, Partnerships...

Continue reading

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress

– AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma– AUTO1/22: oral presentation on initial experience in r/r pediatric B-cell acute lymphoblastic leukemia– obe-cel: poster presentation in r/r primary CNS lymphoma– obe-cel: poster presentation in r/r B-non-Hodgkins lymphoma and chronic lymphoblastic leukemia– Conference call to be held on June 13, 2022 at 7:30 am EST/12:30 pm BST LONDON, May 12, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the online publication of four abstracts submitted to the European Hematology Association (EHA) Congress to be held June 9-12, 2022. Autolus plans to present more detail on these programs and the...

Continue reading

Verizon reports preliminary results of shareholder vote at 2022 annual meeting

IRVING, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) has announced preliminary results of the shareholder vote at its annual meeting, which was held today in Irving, Texas, the company’s first in-person shareholder meeting since 2019. Verizon’s shareholders elected each of Verizon’s eleven directors to a one-year term. Shareholders also voted in favor of two management proposals:Approved the compensation of the company’s named executive officers as described in the 2022 proxy statement; and Ratified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm.All four shareholder proposals were defeated: report on charitable contributions; amend executive compensation clawback policy; shareholder ratification of annual equity awards; and report...

Continue reading

CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline on Thursday, May 12 by Evelo Biosciences, Inc. (Nasdaq: EVLO), please note that in the first sentence of the First Quarter 2022 Financial Results (Unaudited) section, the dates should be “As of March 31, 2022, cash and cash equivalents were $39.6 million, as compared to cash and cash equivalents of $68.4 million as of December 31, 2021,” not December 31, 2021 and March 31, 2021. The corrected release follows: Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the first quarter 2022. “This quarter we reported positive data for EDP1815 in psoriasis in three key areas: effects on systemic inflammatory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.